Skip to main content

Table 1 Demographics of the study subjects

From: Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study

Study Group Number Age (yr) Median (range) Sex (male: female) Race
ASD1     
Test 26 7.6 (2.3–13.4) 25:1 W2 24, H 1, AA 0, A 1
Control 107 4.8 (1.5–17.3) 92:15 W 77, H 7, AA 11, A 9, other 3
CRS/ROM 38 6.8 (1.0–17.8) 27:11 W 12, H 16, AA 8, A 2
FA 24 2.5 (1.0–13.7) 18:6 W 12, H 4, AA 4, A 4
Control 43 7.0 (1.0–13.8) 31:12 W 31, H 6, AA 3, A 3
  1. 1 ASD test group patients were diagnosed with autism (N = 21), pervasive developmental disorder not otherwise specified (PDD-NOS) (N = 4), and ASD (not categorized as autism or PDD-NOS due to age) (N = 1). ASD control group patients were diagnosed with autism (N = 70), PDD-NOS (N = 27), and ASD (not categorized as autism or PDD-NOS due to age) (N = 10).
  2. 2 Abbreviations: W Caucasian, H Hispanic, AA African American, A Asian.